---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-393462"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2026-09-17T01:03:10+00:00"
generated_at: "2026-09-17T10:05:29.397593+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics reduces stockholder quorum requirement to one-third of voting power

## Summary
- Board adopted Second Amended and Restated By-Laws effective September 16, 2026.
- Quorum for stockholder meetings lowered from majority to one-third of outstanding voting power.
- Board and committee quorum unchanged at majority.
- Amendment includes conforming, clarifying, and non-substantive changes.

## SEC filing metadata
- accession: 0001193125-26-393462
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2026-09-17T01:03:10+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/0001193125-26-393462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/tcrt-20260916.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-393462
- JSON: https://secwatch.observer/filing/0001193125-26-393462.json
- Plain text: https://secwatch.observer/filing/0001193125-26-393462.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.